Yilmaz M - Search Results

1

An unusual etiology of erythropoietin resistance: hyperthyroidism.

Kaynar K, Ozkan G, Erem C, Gul S, Yilmaz M, Sonmez B, Ozdemir F, Ulusoy S. Kaynar K, et al. Among authors: yilmaz m. Ren Fail. 2007;29(6):759-61. doi: 10.1080/08860220701460442. Ren Fail. 2007. PMID: 17763175 Free article.

2

Hodgkin's disease and autoimmune hemolytic anemia: a case report.

Ozdemir F, Yilmaz M, Akdogan R, Kaynar K, Kavgaci H, Karti S, Aydin F. Ozdemir F, et al. Among authors: yilmaz m. Med Princ Pract. 2005 May-Jun;14(3):205-7. doi: 10.1159/000084642. Med Princ Pract. 2005. PMID: 15863998 Free article.

3

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu İ, Ersoz HO. Erem C, et al. Among authors: yilmaz m. Endocrine. 2009 Dec;36(3):473-8. doi: 10.1007/s12020-009-9271-2. Epub 2009 Oct 27. Endocrine. 2009. PMID: 19859836

4

Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.

Erem C, Kocak M, Hacihasanoglu A, Yilmaz M. Erem C, et al. Among authors: yilmaz m. J Endocrinol Invest. 2008 Jun;31(6):537-41. doi: 10.1007/BF03346404. J Endocrinol Invest. 2008. PMID: 18591887

5

Effects of interferon-alpha-2a on Th3 cytokine response in multiple myeloma patients.

Sonmez M, Sonmez B, Eren N, Yilmaz M, Karti SS, Ovali E. Sonmez M, et al. Among authors: yilmaz m. Tumori. 2004 Jul-Aug;90(4):387-9. doi: 10.1177/030089160409000404. Tumori. 2004. PMID: 15510980

6

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO. Erem C, et al. Among authors: yilmaz m. Endocrine. 2009 Feb;35(1):75-80. doi: 10.1007/s12020-008-9116-4. Epub 2008 Oct 29. Endocrine. 2009. PMID: 18958631

7

The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.

Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C. Fidan E, et al. Among authors: yilmaz m, yilmaz h. Acta Diabetol. 2011 Dec;48(4):297-302. doi: 10.1007/s00592-011-0276-y. Epub 2011 Mar 23. Acta Diabetol. 2011. PMID: 21424914 Clinical Trial.

8

Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma.

Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O. Erem C, et al. Among authors: yilmaz m. Clin Endocrinol (Oxf). 2010 Oct;73(4):502-7. doi: 10.1111/j.1365-2265.2009.03752.x. Clin Endocrinol (Oxf). 2010. PMID: 20039901

9

Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.

Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O. Erem C, et al. Among authors: yilmaz m. Eur J Endocrinol. 2009 May;160(5):863-8. doi: 10.1530/EJE-09-0069. Epub 2009 Feb 20. Eur J Endocrinol. 2009. PMID: 19233920

10

Effect of pathologic fractures on survival in multiple myeloma patients: a case control study.

Sonmez M, Akagun T, Topbas M, Cobanoglu U, Sonmez B, Yilmaz M, Ovali E, Omay SB. Sonmez M, et al. Among authors: yilmaz m. J Exp Clin Cancer Res. 2008 Jun 10;27(1):11. doi: 10.1186/1756-9966-27-11. J Exp Clin Cancer Res. 2008. PMID: 18577267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,643 results

Search Page

Filters